Search

Search Constraints

You searched for: Author/Creator Usala, Emilio

Search Results

1. Adherence and future discontinuation of tyrosine kinase inhibitors in chronic phase chronic myeloid leukemia. A patient-based survey on 1133 patients. Issue 10 (October 2015)

2. Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second‐generation tyrosine kinase inhibitors in the real‐life practice: Identification of risk factors and the role of prophylaxis. Issue 7 (28th April 2018)

3. Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia. Issue 4 (3rd February 2019)

4. Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia. Issue 6 (6th December 2020)

5. Reproducibility of liver iron concentration measured on a biopsy sample: A validation study in vivo. Issue 2 (19th November 2014)

6. Rotation of nilotinib and imatinib for first‐line treatment of chronic phase chronic myeloid leukemia. Issue 6 (24th April 2016)

7. The BCR‐ABL1 transcript type influences response and outcome in Philadelphia chromosome‐positive chronic myeloid leukemia patients treated frontline with imatinib. Issue 8 (30th May 2017)